• Vir Biotechnology appointed Aziz Sawaf executive vice president and chief financial officer.
• David Liu was named executive vice president and chief medical officer.
• Suzanne Topalian joined the board of directors and its Science and Technology Committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vir Biotechnology Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611041605BIZWIRE_USPR_____20261104_BW025803) on November 04, 2026, and is solely responsible for the information contained therein.